Stem cell therapy in COVID-19: Pooled evidence from SARS-CoV-2, SARS-CoV, MERS-CoV and ARDS: A systematic review
Author:
Publisher
Elsevier BV
Subject
Pharmacology,General Medicine
Reference95 articles.
1. Forty years with coronaviruses;Weiss;J. Exp. Med. [Internet],2020
2. Coronavirus Disease 2019 (COVID-19) [Internet];CDC,2020
3. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding;Lu;Lancet,2020
4. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19;Huang;Acta Pharmacol. Sin.,2020
5. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV;Ou;Nat. Commun.,2020
Cited by 20 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Know an Emotion by the Company It Keeps: Word Embeddings from Reddit/Coronavirus;Applied Sciences;2023-05-31
2. Nanotechnology and stem cell therapy for combating COVID-19;Nanotechnology and Regenerative Medicine;2023
3. Clinical efficacy analysis of mesenchymal stem cell therapy in patients with COVID-19: A systematic review;World Journal of Clinical Cases;2022-09-26
4. pcMSC Modulates Immune Dysregulation in Patients With COVID-19-Induced Refractory Acute Lung Injury;Frontiers in Immunology;2022-04-29
5. Efficacy and safety of mesenchymal stem cells in the treatment of systemic sclerosis: a systematic review and meta-analysis;Stem Cell Research & Therapy;2022-03-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3